Welcome to our dedicated page for ReposiTrak SEC filings (Ticker: TRAK), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
ReposiTrak filings document a Nevada operating company that provides SaaS-based traceability, compliance, risk management, and supply chain applications for retailers, wholesalers, suppliers, and food manufacturers. Its Form 8-K disclosures record quarterly results and earnings-call materials, cash dividend declarations, share repurchase authorizations, and material commercial or financing agreements involving its subsidiary PC Group.
Governance filings cover director appointments, committee assignments, annual meeting voting results, executive compensation advisory votes, and common-stock matters. The disclosures also describe the company's product families, public-company governance framework, capital allocation actions, and regulatory context for food safety and supply chain compliance.
ReposiTrak, Inc. (TRAK) reported Q1 FY2026 results. Revenue was $5,971,467, up 10% year over year, driven by recurring subscription and support services of $5,941,467. Net income was $1,819,529, and diluted EPS was $0.09. Income from operations reached $1,893,873.
Cash and cash equivalents were $28,794,806, with deferred revenue of $2,686,197 and no bank debt. Operating cash flow was $1,538,447. The company redeemed 70,093 shares of Series B Preferred for $749,995 and repurchased 8,715 common shares for $149,985. A quarterly cash dividend of $0.02 per share was declared. As of November 13, 2025, 18,288,455 common shares were outstanding.
Management highlights growth across compliance, supply chain, and traceability offerings as industry mandates expand. Total stockholders’ equity increased to $50,169,744.
ReposiTrak, Inc. (TRAK): CEO, director and 10% owner Randall K. Fields reported two open‑market sales under a Rule 10b5‑1 plan. On 11/10/2025, the RK Fields Charitable 2022, LLC sold 1,600 shares at a weighted average price of $15.0326. On 11/11/2025, it sold 5,900 shares at a weighted average price of $15.0248.
Following these transactions, the charitable LLC held 12,500 shares indirectly. Additional reported holdings include 3,683,955 shares directly; 615,260 shares indirectly by Riverview Financial Corp.; 333,643 shares indirectly by Fields Management, Inc.; 30,667 shares indirectly by spouse; and Series B Preferred holdings of 229,262 shares indirectly by Riverview Financial Corp. and 5,320 shares indirectly by spouse. The filing notes the plan was established to meet charitable commitments.
ReposiTrak (TRAK) disclosed an insider transaction on a Form 4. CEO, Director and 10% owner Randall K. Fields reported a sale of 7,500 shares of common stock on 11/03/2025 at a weighted average price of $15.0126, executed under a Rule 10b5-1 trading plan to meet charitable commitments. The filing notes the shares were sold in multiple trades between $15.00 and $15.10. Following the transaction, reported holdings include 3,683,955 shares direct and various indirect positions, including 20,000 by RK Fields Charitable 2022, LLC.
ReposiTrak (TRAK) disclosed insider transactions by Randall K. Fields, its Chief Executive Officer, director, and 10% owner. Acting through RK Fields Charitable 2022, LLC under a Rule 10b5-1 trading plan, he sold a total of 7,500 shares across three days: 3,800 shares on 10/28/2025 at a weighted average price of $15.2786, 1,000 shares on 10/29/2025 at $15.1774, and 2,700 shares on 10/30/2025 at $14.9978. The plan was established to meet charitable commitments.
Following the reported transactions, beneficial holdings included 27,500 shares indirectly by RK Fields Charitable 2022, LLC and 3,683,955 shares held directly, with additional indirect holdings reported through Riverview Financial Corp., his spouse, and Fields Management, Inc., as well as Series B Preferred Stock holdings.
ReposiTrak, Inc. (TRAK) CEO, Director, and 10% owner Randall K. Fields reported a sale of common stock on 10/20/2025. The filing shows a disposition of 7,500 shares coded “S,” executed under a Rule 10b5-1 trading plan established to meet charitable commitments.
The weighted average sale price was $15.467, with individual trades ranging from $14.80 to $15.21. Following the reported transaction, the filing lists 35,000 shares indirectly held by RK Fields Charitable 2022, LLC.
Additional beneficial holdings disclosed include 3,683,955 shares (direct), 615,260 shares indirectly by Riverview Financial Corp., 30,667 shares indirectly by spouse, and 333,643 shares indirectly by Fields Management, Inc. The filing also lists Series B Preferred Stock positions: 289,673 shares indirectly by Riverview Financial Corp. and 6,721 shares indirectly by spouse.
ReposiTrak (TRAK) disclosed that CEO, director and 10% owner Randall K. Fields sold a total of 7,500 shares of common stock on October 14–15, 2025 under a Rule 10b5-1 trading plan executed through RK Fields Charitable 2022, LLC, established to help meet charitable commitments.
Transactions included: 1,500 shares at a weighted average price of $14.7377 on 10/14, 1,640 shares at $14.4227 on 10/14, and 4,360 shares at $14.4227 on 10/15. Following these sales, the filing shows 42,500 shares held indirectly by the charitable LLC and 3,683,955 shares held directly, alongside additional indirect holdings through affiliated entities.
Randall K. Fields, who serves as Chief Executive Officer, Director and a >10% owner of ReposiTrak, Inc. (TRAK), reported a sale of 7,500 shares of common stock on 10/07/2025 at a weighted average price of $14.9711 per share under a Rule 10b5-1 trading plan. The filing shows substantial remaining holdings: 3,683,955 shares held directly, 615,260 shares indirectly via Riverview Financial Corp., 333,643 via Fields Management, Inc., and other indirect holdings including 50,000 shares held by RK Fields Charitable 2022, LLC.
The sale was executed automatically to satisfy charitable commitments and occurred across multiple transactions with prices ranging from $14.16 to $15.21. No derivative securities were reported as changed in this filing.
Randall K. Fields, CEO, director and 10% owner of ReposiTrak, Inc. (TRAK), reported multiple sales of Common Stock under an existing Rule 10b5-1 trading plan established to meet charitable commitments. The Form 4 shows five reported dispositions executed on 09/29/2025, 09/30/2025 and 10/01/2025 totaling 7,500 shares sold at weighted-average prices ranging from approximately $14.91 to $16.97 per share. The sales were made indirectly by RK Fields Charitable 2022, LLC pursuant to the trustee role in a charitable remainder unitrust. The filing lists significant remaining holdings held directly and indirectly, including large direct and indirect positions in common stock and Series B preferred stock across related entities and spouse holdings.
ReposiTrak, Inc. filed a current report to let investors know it has released its latest financial results. On September 29, 2025, the company issued a press release and held an earnings call covering its financial performance for the fiscal quarter and year ended June 30, 2025.
The press release is included as Exhibit 99.1 and the earnings call transcript as Exhibit 99.2. The company notes that this information is being furnished rather than filed, which limits how it is treated under certain securities law liability provisions.
ReposiTrak, Inc. (TRAK) reports operational and financial disclosures in its Form 10-K. The company states it has not identified any cybersecurity threats that have materially affected or are reasonably likely to materially affect its business, and it maintains employee reporting procedures and quarterly Audit Committee reviews of cybersecurity policies. Contract asset balances at June 30, 2025 include a current contract asset of $428,585. The company reports zero bank debt and a revolving credit facility balance of zero as of June 30, 2025, while maintaining cash/liquid assets above previously required covenant levels. Common stock details show 336,098 and 616,470 shares issued and outstanding at June 30, 2025 and 2024 (par $0.01), and total common shares outstanding of 18,282,805 at June 30, 2025. The company disclosed lease arrangements with no future lease commitments under a prior lease and a month-to-month office lease treated as short-term. It disclosed stock plans (2023 Plan and ESPP), warrant activity, and preferred stock designations including 700,000 Series B Preferred with dividend rates of 7% (cash) or 9% (paid-in-kind) and a redemption price of $10.70 per share. The company repurchased 2,131,384 common shares at an average of $6.20 and has $7,792,173 remaining under its repurchase program as of June 30, 2025.